IPAD-DB ID | C00551 |
Name | Ginsenoside F1 |
Category | Natural compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 3 6 H 6 2 O 9 |
Molecular Weight | 638.9 g/mol |
IUPAC Name | (2R, 3S, 4S, 5R, 6S)-2-(hydroxymethyl)-6-[(2S)-6-methyl-2-[(3S, 5R, 6S, 8R, 9R, 10R, 12R, 13R, 14R, 17S)-3, 6, 12-trihydroxy-4, 4, 8, 10, 14-pentamethyl-2, 3, 5, 6, 7, 9, 11, 12, 13, 15, 16, 17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxyoxane-3, 4, 5-triol |
InChI | InChI=1S/C36H62O9/c1-19(2)10-9-13-36(8, 45-31-29(43)28(42)27(41)23(18-37)44-31)20-11-15-34(6)26(20)21(38)16-24-33(5)14-12-25(40)32(3, 4)30(33)22(39)17-35(24, 34)7/h10, 20-31, 37-43H, 9, 11-18H2, 1-8H3/t20-, 21+, 22-, 23+, 24+, 25-, 26-, 27+, 28-, 29+, 30-, 31-, 33+, 34+, 35+, 36-/m0/s1 |
InChIKey | XNGXWSFSJIQMNC-FIYORUNESA-N |
Canonical SMILES | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)O)C)O)C)OC5C(C(C(C(O5)CO)O)O)O)C |
PubChem CID | 9809542 |
DrugBank Accession Number | - |
CAS Registry Number | 53963-43-2 |
Molecular Weight(Computed by SwissADME) | 638.87 |
Hac(Computed by SwissADME) | 45 |
Volume(Computed by ADMETlab 2.0) | 664.905 |
Density(Computed by ADMETlab 2.0) | 0.96 |
nRing(Computed by ADMETlab 2.0) | 5 |
MaxRing(Computed by ADMETlab 2.0) | 17 |
nHet(Computed by ADMETlab 2.0) | 9 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 27 |
Flexibility(Computed by ADMETlab 2.0) | 0.259 |
Stero Centers(Computed by ADMETlab 2.0) | 16 |
LogS(Computed by ADMETlab 2.0) | -3.441 |
LogD(Computed by ADMETlab 2.0) | 3.626 |
logP(Computed by ADMETlab 2.0) | 3.416 |
TPSA(Computed by SwissADME) | 160.07 |
Hbond Acceptor(Computed by SwissADME) | 9 |
Hbond Donor(Computed by SwissADME) | 7 |
Rotatable Bonds(Computed by SwissADME) |
GI Absorption(Computed by SwissADME) | Low |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
P-gp Substrate(Computed by SwissADME) | Yes |
CYP1A2 Inhibitor(Computed by SwissADME) | No |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -7.17 |
Lipinski(Computed by SwissADME) | 2 |
Ghose(Computed by SwissADME) | 3 |
Veber(Computed by SwissADME) | 1 |
Egan(Computed by SwissADME) | 1 |
Muegge(Computed by SwissADME) | 3 |
Bioavailability Score(Computed by SwissADME) | 0.17 |